Bone · Musculoskeletal
Denosumab (Prolia) in Menopause
Twice-yearly injection — mechanism, side effects, discontinuation trap.
Twice-yearly injection — mechanism, side effects, discontinuation trap. Kindr Health integrates bone and musculoskeletal care into every menopause plan.
Assessment
DEXA scan timing, FRAX calculation, vitamin D and calcium status, and physical function screening.
Treatment layers
HRT for early prevention when appropriate, bisphosphonates or anabolics for established disease, resistance training, protein optimization, and coordination with orthopedics or rheumatology when needed.
Frequently asked questions
Is HRT enough for bone?
For prevention in early menopause, often yes. Established osteoporosis needs bone-specific therapy.
When should I get a DEXA?
Standard at 65, earlier with risk factors or early menopause.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.